ANTX - AN2 Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.23 0.01 (0.41%)	---	---	---	---	0.01 (0.41%)	0.0 (0.0%)	0.0 (0.0%)

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.21
Diluted EPS:: -0.21
Basic P/E:: -5.881
Diluted P/E:: -5.881
RSI(14) 1m:: 60.24
VWAP:: 1.24
RVol:: 0.2287

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	1.26 +0.02 (+1.37%)	Oct 15 12:42
1m	Price increase 1m	1.26 +0.02 (+1.61%)	Oct 15 11:46
10m	Price decrease 10m	1.21 -0.04 (-3.19%)	Oct 15 11:34
1m	Price increase 1m	1.26 +0.05 (+4.13%)	Oct 15 09:46
10m	Price increase 10m	1.26 +0.05 (+4.13%)	Oct 15 09:46